Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 10.52% is 14% above its 5-year average of 9.19%, around the middle of its 5-year range (4.33%–24.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.19% above its 12-month average of 9.37%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
10.52%
NET PROFIT MARGIN AVG TTM
9.37%
NET PROFIT MARGIN AVG 3Y
9.13%
NET PROFIT MARGIN AVG 5Y
9.19%
NET PROFIT MARGIN AVG 10Y
9.74%
NET PROFIT MARGIN AVG 15Y
9.14%
NET PROFIT MARGIN AVG 20Y
8.90%
CURRENT VS TTM AVG
+12.19%
CURRENT VS 3Y AVG
+15.16%
CURRENT VS 5Y AVG
+14.38%
CURRENT VS 10Y AVG
+7.98%
CURRENT VS 15Y AVG
+15.10%
CURRENT VS 20Y AVG
+18.09%
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+21.15%
vs the sector median at left
Quest Diagnostics Incorporated
Market Cap
$26.24B
Net Profit Margin
10.52%
TTM Avg
9.37%
3Y Avg
9.13%
5Y Avg
9.19%
Market Cap
$26.53B
Net Profit Margin
6.99%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$25.26B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$24.79B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$24.48B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$29.07B
Net Profit Margin
21.91%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
Market Cap
$29.97B
Net Profit Margin
16.82%
TTM Avg
-1.96%
3Y Avg
-34.26%
5Y Avg
-68.70%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $26.24B | 10.52% | 9.37% | 9.13% | 9.19% |
| Labcorp Holdings Inc. (LH)vs › | $26.53B | 6.99% | 6.01% | 6.56% | 9.24% |
| Moderna, Inc. (MRNA)vs › | $25.26B | -141.43% | -128.24% | -70.25% | -50.87% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.79B | 16.98% | 16.55% | 18.38% | 18.84% |
| Incyte Corporation (INCY)vs › | $24.48B | 27.71% | 12.90% | 13.00% | 12.11% |
| Mettler-Toledo International Inc. (MTD)vs › | $29.07B | 21.91% | 21.94% | 21.74% | 21.20% |
| BioNTech SE (BNTX)vs › | $23.30B | -62.98% | -31.89% | 3.77% | 12.08% |
| STERIS plc (STE)vs › | $23.06B | 13.31% | 12.25% | 8.55% | 8.79% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $29.97B | 16.82% | -1.96% | -34.26% | -68.70% |
| Medline Inc. (MDLN)vs › | $30.02B | 3.31% | 4.39% | 2.42% | 2.42% |
Operating Margin
14.1%
Net Profit Margin
10.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 10.52% |
| 2026-03-31 | 8.70% |
| 2025-12-31 | 8.73% |
| 2025-09-30 | 8.70% |
| 2025-06-30 | 10.21% |
| 2025-03-31 | 8.30% |
| 2024-12-31 | 8.47% |
| 2024-09-30 | 9.08% |
| 2024-06-30 | 9.55% |
| 2024-03-31 | 8.20% |
| 2023-12-31 | 8.39% |
| 2023-09-30 | 9.80% |
| 2023-06-30 | 10.05% |
| 2023-03-31 | 8.67% |
| 2022-12-31 | 4.33% |
| 2022-09-30 | 10.22% |
| 2022-06-30 | 9.50% |
| 2022-03-31 | 13.56% |
| 2021-12-31 | 14.18% |
| 2021-09-30 | 18.13% |
| 2021-06-30 | 24.63% |
| 2021-03-31 | 17.21% |
| 2020-12-31 | 19.19% |
| 2020-09-30 | 20.32% |
| 2020-06-30 | 10.07% |
| 2020-03-31 | 5.43% |
| 2019-12-31 | 13.14% |
| 2019-09-30 | 10.94% |
| 2019-06-30 | 10.55% |
| 2019-03-31 | 8.62% |
| 2018-12-31 | 6.85% |
| 2018-09-30 | 11.22% |
| 2018-06-30 | 11.41% |
| 2018-03-31 | 9.34% |
| 2017-12-31 | 13.07% |
| 2017-09-30 | 8.29% |
| 2017-06-30 | 9.93% |
| 2017-03-31 | 8.58% |
| 2016-12-31 | 8.33% |
| 2016-09-30 | 10.08% |
| 2016-06-30 | 10.18% |
| 2016-03-31 | 5.53% |
| 2015-12-31 | 10.17% |
| 2015-09-30 | 18.09% |
| 2015-06-30 | 6.08% |
| 2015-03-31 | 3.32% |
| 2014-12-31 | 10.09% |
| 2014-09-30 | 6.72% |
| 2014-06-30 | 6.99% |
| 2014-03-31 | 5.90% |
| 2013-12-31 | 8.09% |
| 2013-09-30 | 22.61% |
| 2013-06-30 | 9.09% |
| 2013-03-31 | 7.56% |
| 2012-12-31 | 3.15% |
| 2012-09-30 | 8.77% |
| 2012-06-30 | 9.28% |
| 2012-03-31 | 8.19% |
| 2011-12-31 | 10.08% |
| 2011-09-30 | 9.01% |
| 2011-06-30 | 8.57% |
| 2011-03-31 | 7.73% |
| 2010-12-31 | 9.09% |
| 2010-09-30 | 10.62% |
| 2010-06-30 | 10.38% |
| 2010-03-31 | 9.00% |
| 2009-12-31 | 9.82% |
| 2009-09-30 | 10.13% |
| 2009-06-30 | 9.90% |
| 2009-03-31 | 9.24% |
| 2008-12-31 | 9.43% |
| 2008-09-30 | 6.06% |
| 2008-06-30 | 8.78% |
| 2008-03-31 | 7.82% |
| 2007-12-31 | -0.30% |
| 2007-09-30 | 5.54% |
| 2007-06-30 | 8.61% |
| 2007-03-31 | 6.94% |
| 2006-12-31 | 9.64% |
| 2006-09-30 | 10.14% |
| 2006-06-30 | 8.33% |
| 2006-03-31 | 9.30% |
| 2005-12-31 | 9.08% |
| 2005-09-30 | 9.86% |
| 2005-06-30 | 10.82% |
| 2005-03-31 | 9.97% |
| 2004-12-31 | 9.82% |
| 2004-09-30 | 10.09% |
| 2004-06-30 | 9.77% |
| 2004-03-31 | 9.25% |
| 2003-12-31 | 8.99% |
| 2003-09-30 | 9.83% |
| 2003-06-30 | 9.87% |
| 2003-03-31 | 8.06% |
| 2002-12-31 | 7.90% |
| 2002-09-30 | 8.18% |
